FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2003944379> ?p ?o ?g. }

• W2003944379 endingPage "949" @default.
• W2003944379 startingPage "942" @default.
• W2003944379 abstract "Objective. To access the correlation of Chromogranin A (CgA) with inflammatory bowel disease (IBD) activity and responsiveness to medical therapy. Material and methods. A prospective observational study was conducted in 56 patients with moderate ulcerative colitis (UC) or Crohn’s disease (CD) (UC, n = 29, CD, n = 27), 17 patients with irritable bowel syndrome and predominant diarrhea (IBS-D) and 40 healthy volunteers. IBD patients were treated by biologics (infliximab or adalimumab) or conventional agents (aminosalicylates, thiopurines or methotrexate and steroids) and were classified according to their treatment in two groups. Serum CgA was measured at baseline and 4-week posttreatment period. Results. Serum CgA was significantly higher in IBD patients than in those with IBS-D or healthy volunteers (p < 0.01). Furthermore, serum CgA was markedly increased in CD patients than in UC patients (p < 0.01). CgA value was significantly reduced in ‘biologic’ group (24 IBD patients, UC, n = 15, CD, n = 9) at 4-week posttreatment period (p < 0.01), while 18/24 (72%) patients were already in remission during that time. In contrast, CgA value was significantly increased in the ‘conventional’ treatment group (32 IBD patients, UC, n = 14, CD, n = 18) between the two visits (p < 0.01), although 22/32 (69%) patients were in remission during the 4-week posttreatment period. Conclusion. CgA appears to be a reliable marker of disease activity in IBD patients and especially in those who received biologic therapy. IBS-D patients presented normal CgA values." @default.
• W2003944379 created "2016-06-24" @default.
• W2003944379 creator A5007395679 @default.
• W2003944379 creator A5012150744 @default.
• W2003944379 creator A5012987221 @default.
• W2003944379 creator A5016385576 @default.
• W2003944379 creator A5025124886 @default.
• W2003944379 creator A5071642148 @default.
• W2003944379 creator A5086951145 @default.
• W2003944379 creator A5088466238 @default.
• W2003944379 date "2014-06-04" @default.
• W2003944379 modified "2023-09-24" @default.
• W2003944379 title "Chromogranin A as a biomarker of disease activity and biologic therapy in inflammatory bowel disease: a prospective observational study" @default.
• W2003944379 cites W127134954 @default.
• W2003944379 cites W1971120442 @default.
• W2003944379 cites W1977934005 @default.
• W2003944379 cites W1983542509 @default.
• W2003944379 cites W1991701413 @default.
• W2003944379 cites W1997563646 @default.
• W2003944379 cites W2015025080 @default.
• W2003944379 cites W2016723022 @default.
• W2003944379 cites W2016912110 @default.
• W2003944379 cites W2026668428 @default.
• W2003944379 cites W2064201279 @default.
• W2003944379 cites W2072287846 @default.
• W2003944379 cites W2073869462 @default.
• W2003944379 cites W2075602859 @default.
• W2003944379 cites W2077706903 @default.
• W2003944379 cites W2079267300 @default.
• W2003944379 cites W2081852251 @default.
• W2003944379 cites W2083711376 @default.
• W2003944379 cites W2087551258 @default.
• W2003944379 cites W2102087425 @default.
• W2003944379 cites W2110016520 @default.
• W2003944379 cites W2110254924 @default.
• W2003944379 cites W2113068598 @default.
• W2003944379 cites W2118019855 @default.
• W2003944379 cites W2120522488 @default.
• W2003944379 cites W2125123579 @default.
• W2003944379 cites W2127981125 @default.
• W2003944379 cites W2140741976 @default.
• W2003944379 cites W2143658660 @default.
• W2003944379 cites W2170551980 @default.
• W2003944379 cites W2171789845 @default.
• W2003944379 cites W2319457872 @default.
• W2003944379 cites W3149527659 @default.
• W2003944379 doi "https://doi.org/10.3109/00365521.2014.920910" @default.
• W2003944379 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25228025" @default.
• W2003944379 hasPublicationYear "2014" @default.
• W2003944379 type Work @default.
• W2003944379 sameAs 2003944379 @default.
• W2003944379 citedByCount "28" @default.
• W2003944379 countsByYear W20039443792014 @default.
• W2003944379 countsByYear W20039443792015 @default.
• W2003944379 countsByYear W20039443792016 @default.
• W2003944379 countsByYear W20039443792017 @default.
• W2003944379 countsByYear W20039443792018 @default.
• W2003944379 countsByYear W20039443792019 @default.
• W2003944379 countsByYear W20039443792020 @default.
• W2003944379 countsByYear W20039443792021 @default.
• W2003944379 countsByYear W20039443792022 @default.
• W2003944379 countsByYear W20039443792023 @default.
• W2003944379 crossrefType "journal-article" @default.
• W2003944379 hasAuthorship W2003944379A5007395679 @default.
• W2003944379 hasAuthorship W2003944379A5012150744 @default.
• W2003944379 hasAuthorship W2003944379A5012987221 @default.
• W2003944379 hasAuthorship W2003944379A5016385576 @default.
• W2003944379 hasAuthorship W2003944379A5025124886 @default.
• W2003944379 hasAuthorship W2003944379A5071642148 @default.
• W2003944379 hasAuthorship W2003944379A5086951145 @default.
• W2003944379 hasAuthorship W2003944379A5088466238 @default.
• W2003944379 hasConcept C126322002 @default.
• W2003944379 hasConcept C185592680 @default.
• W2003944379 hasConcept C188816634 @default.
• W2003944379 hasConcept C204232928 @default.
• W2003944379 hasConcept C2777138892 @default.
• W2003944379 hasConcept C2778260677 @default.
• W2003944379 hasConcept C2778271842 @default.
• W2003944379 hasConcept C2779134260 @default.
• W2003944379 hasConcept C2779280984 @default.
• W2003944379 hasConcept C2780132546 @default.
• W2003944379 hasConcept C2780479503 @default.
• W2003944379 hasConcept C2781059491 @default.
• W2003944379 hasConcept C2781197716 @default.
• W2003944379 hasConcept C55493867 @default.
• W2003944379 hasConcept C71924100 @default.
• W2003944379 hasConcept C77231918 @default.
• W2003944379 hasConcept C90924648 @default.
• W2003944379 hasConceptScore W2003944379C126322002 @default.
• W2003944379 hasConceptScore W2003944379C185592680 @default.
• W2003944379 hasConceptScore W2003944379C188816634 @default.
• W2003944379 hasConceptScore W2003944379C204232928 @default.
• W2003944379 hasConceptScore W2003944379C2777138892 @default.
• W2003944379 hasConceptScore W2003944379C2778260677 @default.
• W2003944379 hasConceptScore W2003944379C2778271842 @default.
• W2003944379 hasConceptScore W2003944379C2779134260 @default.
• W2003944379 hasConceptScore W2003944379C2779280984 @default.
• W2003944379 hasConceptScore W2003944379C2780132546 @default.

• next